AU2003234650A1 - 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents - Google Patents

3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents Download PDF

Info

Publication number
AU2003234650A1
AU2003234650A1 AU2003234650A AU2003234650A AU2003234650A1 AU 2003234650 A1 AU2003234650 A1 AU 2003234650A1 AU 2003234650 A AU2003234650 A AU 2003234650A AU 2003234650 A AU2003234650 A AU 2003234650A AU 2003234650 A1 AU2003234650 A1 AU 2003234650A1
Authority
AU
Australia
Prior art keywords
mmol
compound
stirred
methanol
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003234650A
Other languages
English (en)
Inventor
Todd C. Henninger
Mark J. Macielag
Brett A. Marinelli
Bin Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU2003234650A1 publication Critical patent/AU2003234650A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2003234650A 2002-05-31 2003-05-28 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents Abandoned AU2003234650A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38448302P 2002-05-31 2002-05-31
US60/384,483 2002-05-31
PCT/US2003/016617 WO2003102010A1 (en) 2002-05-31 2003-05-28 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents

Publications (1)

Publication Number Publication Date
AU2003234650A1 true AU2003234650A1 (en) 2003-12-19

Family

ID=29712041

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003234650A Abandoned AU2003234650A1 (en) 2002-05-31 2003-05-28 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents

Country Status (7)

Country Link
US (1) US6825172B2 (https=)
EP (1) EP1513856A1 (https=)
JP (1) JP2005531603A (https=)
CN (1) CN1671726A (https=)
AU (1) AU2003234650A1 (https=)
CA (1) CA2487918A1 (https=)
WO (1) WO2003102010A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100695322B1 (ko) 2005-02-23 2007-03-15 (주)에스.앤.디 메밀등겨로부터 수용성섬유소 및 파고피리톨의 저온 및 연속추출 방법
US20090075916A1 (en) * 2005-11-23 2009-03-19 Upadhyay Dilip J Use of Macrolide Derivatives for Treating Acne
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
EP2871188B1 (en) * 2012-07-06 2017-04-19 Godo Shusei Co., Ltd. Method for separating cyclic macrolide compound

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
IL114589A (en) 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
KR19990067492A (ko) * 1995-11-08 1999-08-25 스티븐 에프. 웨인스톡 트리사이클릭 에리트로마이신 유도체
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
DE69733723T2 (de) 1996-09-04 2006-04-20 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
AU720921B2 (en) 1996-11-27 2000-06-15 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
US6037137A (en) * 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
ZA989835B (en) * 1997-10-29 1999-05-05 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
WO1999021870A1 (en) 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
US6169168B1 (en) 1997-10-29 2001-01-02 Taisho Pharmaceuticals Co., Ltd. Erythromycin A derivatives
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
US6020521A (en) 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
ID30547A (id) 1999-04-16 2001-12-20 Kosan Biosciences Inc Zat anti-infeksi makrolida
IL145976A0 (en) 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials
GB9910079D0 (en) 1999-05-01 1999-06-30 Smithkline Beecham Plc Novel compounds
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
ATE250076T1 (de) 1999-06-07 2003-10-15 Abbott Lab 6-o-carbamat ketolide derivate
WO2001010880A1 (fr) 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
WO2001010878A1 (fr) 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
US6498146B1 (en) * 1999-10-28 2002-12-24 Pfizer Inc Erythromycin derivatives
EP1146051A3 (en) 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
NZ533282A (en) * 2001-12-05 2006-09-29 Ortho Mcneil Pharm Inc 6-O-Acyl ketolide derivatives of erythromycine useful as antibacterials

Also Published As

Publication number Publication date
CN1671726A (zh) 2005-09-21
WO2003102010A1 (en) 2003-12-11
EP1513856A1 (en) 2005-03-16
CA2487918A1 (en) 2003-12-11
JP2005531603A (ja) 2005-10-20
US20040018994A1 (en) 2004-01-29
US6825172B2 (en) 2004-11-30

Similar Documents

Publication Publication Date Title
US6472372B1 (en) 6-O-Carbamoyl ketolide antibacterials
US6124269A (en) 2-Halo-6-O-substituted ketolide derivatives
US6054435A (en) 6-O-substituted macrolides having antibacterial activity
US6046171A (en) 6,11-bridged erythromycin derivatives
AP1189A (en) C-4"-substituted macrolide derivatives.
EP0895999A1 (en) C-4" substituted macrolide antibiotics
EP1642901A1 (en) Novel erythromycin derivatives
US5780605A (en) 6,9-bridged erythromycin derivatives
AU751448B2 (en) 2-halo-6-O-substituted ketolide derivatives
EP0862576A1 (en) 6-0-methyl erythromycin d and process for making
WO1997042205A1 (en) 3-descladinose-2,3-anhydroerythromycin derivatives
US6825170B2 (en) 6-O-acyl ketolide antibacterials
US6713455B2 (en) 6-O-carbamate-11,12-lacto-ketolide antimicrobials
US6825172B2 (en) 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
EP0262904A2 (en) Modifications of mycinose and 3-0-demethylmycinose in tylosintype macrolides
US20050250713A1 (en) 11,12-Cyclic thiocarbamate macrolide antibacterial agents
JP2005538927A (ja) アミドマクロライド
WO2006047167A2 (en) 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application